High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial
International Journal of Antimicrobial Agents (2022) - Comments
pubmed: 34999239  doi: 10.1016/j.ijantimicag.2021.106516  issn: 0924-8579  issn: 1872-7913 

Dora Buonfrate, Fabio Chesini, Davide Martini, Maria Carla Roncaglioni, Maria Luisa Ojeda Fernandez, Maria Francesca Alvisi, Irene De Simone, Eliana Rulli, Alessandro Nobili, Giacomo Casalini, Spinello Antinori, Marco Gobbi, Caterina Campoli, Michela Deiana, Elena Pomari, Gianluigi Lunardi, Roberto Tessari, Zeno Bisoffi